Table 2 –
clinical factor of interest in model | Risk ratio for an association with CAC ≥ 100 model 1a | p-value | Risk ratio for an association with CAC ≥ 100 model 2b | p-value |
---|---|---|---|---|
DCCT-severe hypoglycemia rate | 1.12 (0.99–1.29) | 0.093 | 1.13 (0.97–1.32) | 0.11 |
DCCT-AIC | 1.21 (1.09–1.35) | <0.001 | 1.21 (1.03–1.42) | <0.05 |
Model 1: Adjusted for gender, baseline age; The p-value for group treatment when included in the model was 0.7.
Model 2: Adjusted for group treatment, systolic blood pressure, LDL-cholesterol, BMI, smoking, baseline clinical neuropathy, baseline diabetes duration, baseline hypoglycemia, scanning site, baseline retinopathy, and baseline-AER. p-value for group treatment was 0.71).